Enbrel Once-Weekly Dosing Will Help “Neutralize” Humira Advantage – Amgen
Executive Summary
Amgen hopes a once-weekly dosing regimen for Enbrel will help offset Humira's biweekly dosing advantage, Exec VP-Global Communications Operations George Morrow says
You may also be interested in...
Amgen Enbrel 50 Mg Syringe Expected To Simplify Dosing For Psoriasis
Amgen expects to receive approval by year-end for an Enbrel 50 mg pre-filled syringe that could simplify dosing of the TNF inhibitor for treatment of plaque psoriasis and other indications
Amgen Enbrel 50 Mg Syringe Expected To Simplify Dosing For Psoriasis
Amgen expects to receive approval by year-end for an Enbrel 50 mg pre-filled syringe that could simplify dosing of the TNF inhibitor for treatment of plaque psoriasis and other indications
Amgen Projects Neulasta Sales Driven By Prescribing Growth, Not Switches
Amgen expects Neulasta (pegfilgrastim) 2004 sales to be driven by an increase in the patient population and changes in prescribing patterns